You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Screening for Alcohol-Related Liver Disease Using Breath Signatures by DMS

    SBC: APPLIED NANOTECH, INC.            Topic: NIAAA

    DESCRIPTION (provided by applicant): Alcohol abuse is rampant in the U.S., estimates run as high as 1 in 20 adults, and cost tens of billions of dollars in treatment and economic loss. One especially intransigent problem has been alcohol-induced organ disease such as alcoholic hepatitis and cirrhosis. These diseases can currently be diagnosed, but this requires invasive procedures such as liver bi ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. A rapid, accurate, and easy-to-use diagnostic assay for STIs

    SBC: AI BIOSCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The aim of this application is to develop a rapid, easy-to-use, and inexpensive multi-sample diagnostic system to identify sexually transmitted infection (STI) pathogens, such as Chlamydia trachomatis (CT) and Neisseriagonorrhoeae (NG) in non-traditional healthcare settings. According to the CDC, chlamydia and gonorrhea, caused by C. trachomatis and N. gonorrho ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. A Sensitive and Serotype-Specific Dengue Diagnostic Test for Low-Resource Setting

    SBC: AI BIOSCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Dengue is transmitted mainly by the Aedes aegypti mosquitoes which inhabit the tropics, making Dengue endemic to these areas. It is caused by four genetically and serologically related viruses, termed DENV1, DENV2, DENV3, and DENV4. Dengue infection is a leading cause of illness and death in the tropics and subtropics, including Puerto Rico and the U.S. Virgin ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Enhanced Efficacy Photodynamic Disinfection

    SBC: LYNNTECH INC.            Topic: NIAID

    PROJECT SUMMARY This proposal is in response to the NIAID Advanced Technology SBIR (PA-10-123) Funding Opportunity. This Phase I feasibility study is an advanced technology project with a clearly identified product that will result in a clinically relevanttopical AM treatment modality. The award period and amount requested are guided by project needs and are in compliance with the issued guideline ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Optoacoustic tomography system for image-guided cryotherapy of prostate cancer

    SBC: TOMOWAVE LABORATORIES, INC.            Topic: NCI

    Summary / Abstract The objective of this Phase-I SBIR project is to develop a novel transrectal optoacoustic-ultrasonic (OU) imaging system for guiding cryotherapy of prostate cancer via real-time monitoring of ice ball formation and temperature distribution within the area of healthy tissues adjacent to the rectal wall. The proposed system will be capable of (i) non-invasive monitoring of spatial ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Inhibiting PLEKHA7 for mutant KRAS therapy

    SBC: PHusis Therapeutics Inc            Topic: NCI

    DESCRIPTION (provided by applicant): Oncogenic KRAS is found in 25% of patient tumors across many cancer types. Despite extensive effort since its discovery over 30 years ago there is still no effective treatment for KRAS tumors. An estimated 350,000 patients in the US in 2013 will be diagnosed with mutated KRAS in their tumor, and many will die of their disease. Mutated KRAS plays a critical role ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Targeted Theranostics for Metastatic Melanoma

    SBC: RADIOMEDIX, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): The American Cancer Society reports that death rates for melanoma have been rising in the United States for the past 30 years. It is one of the more common cancers in population younger than 30, and the most common cancer in adults ages 25 to 29. One characteristic of metastatic melanoma cells that is recognized as a potential target for new therapies is their ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Using 3d bioprinting for Nipple Areola Complex (NAC) reconstruction

    SBC: TEVIDO BIODEVICES, INC.            Topic: NCI

    TeVido Project Summary/Abstract Globally, in 2010, there were slightly more than 1 million incidences of breast cancer. In the US ~200,000 women are diagnosed with breast cancer annually and nearly 40% will undergo mastectomies, full removal of the breast.In the US in 2010, more than 93,000 breast reconstructions were performed due to cancer. Patients with loss of the nipple areola complex (NAC) f ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Automated Daily Dose Reconstruction and Delivery Verification for External Beam Radiotherapy

    SBC: MOBIUS MEDICAL SYSTEMS, L.P.            Topic: NCI

    ? DESCRIPTION (provided by applicant): Abstract Approximately half of the 1.6 million people diagnosed with cancer in 2013 in the United States will receive radiation therapy in the management of their disease. Because each course of radiation therapy is tailored to the disease and anatomy of the patient, delivery of the intended dose is dependent upon, in part, the ability of the treatm ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Development of a software package for speech therapy.

    SBC: VULINTUS, INC            Topic: NIDCD

    DESCRIPTION (provided by applicant): We propose the development of Optic-speech, a system designed to use real-time animation of 3D models to visualize tongue movement during speech for use in guiding speech therapy for dysarthria. Approximately 3 millionAmericans suffer from dysarthria yearly, and the inability to speak can quickly lead to a reduced quality of life. Existing therapies can be inte ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government